lipoxin a4 has been researched along with Stroke in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Golab-Janowska, M; Kotlega, D; Nowacki, P; Szczuko, M; Zembron-Lacny, A | 1 |
Miao, Z; Schultzberg, M; Wang, X; Xu, X; Zhao, Y | 1 |
Alexander, JC; Candelario-Jalil, E; de Leon, LG; DeMars, KM; Febo, M; Frankowski, JC; Garrett, TJ; Graves, C; Hawkins, KE; McCrea, AO; Pacheco, SC; Yang, C | 1 |
Ballesteros, I; Caso, JR; Fernández-López, D; Hurtado, O; Lizasoain, I; Moro, MA; Nombela, F; Pereira, MP; Pradillo, JM; Serena, J; Sobrado, M; Vivancos, J | 1 |
1 trial(s) available for lipoxin a4 and Stroke
Article | Year |
---|---|
The Association of Free Fatty Acids and Eicosanoids with the Severity of Depressive Symptoms in Stroke Patients.
Topics: Depression; Docosahexaenoic Acids; Fatty Acids, Nonesterified; Female; Follow-Up Studies; Humans; Lipoxins; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stroke | 2020 |
3 other study(ies) available for lipoxin a4 and Stroke
Article | Year |
---|---|
Reduced Levels of Plasma Lipoxin A4 Are Associated with Post-Stroke Cognitive Impairment.
Topics: Cognitive Dysfunction; Female; Humans; Inflammation Mediators; Lipoxins; Male; Mental Status and Dementia Tests; Middle Aged; Stroke | 2021 |
Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Heptanoic Acids; Infarction, Middle Cerebral Artery; Inflammation; Lipoxins; Male; Microglia; Protective Factors; Rats; Rats, Sprague-Dawley; Recovery of Function; Stroke; Time | 2017 |
Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Brain Infarction; Infarction, Middle Cerebral Artery; Leukotriene B4; Lipoxins; Mice; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Stroke; Thiazolidinediones | 2009 |